Cancer Survivor, Young Adult
Conditions
Brief summary
Investigators will test an evidence-based behavioral intervention that is responsive to Young Adults (YA's) expressed needs and priorities
Interventions
Participants will attend group sessions with a trained facilitator held over videoconference. Sessions will each last 2 hours and will be held once weekly for 10 weeks. Sessions will include Cognitive-Behavioral Stress Management and health education content.
Sponsors
Study design
Eligibility
Inclusion criteria
* 18-39 years old * Diagnosed with cancer between 18-39 years old * Cancer diagnosis was non-metastatic * Completed cancer treatment between 1 month and 5 years prior to enrollment, with the exception of ongoing hormone therapy * No documented or observable psychiatric or neurological disorders that could interfere with participation (e.g., active psychosis, active substance abuse), as identified by the referring medical team, chart review, or screening * Able to speak and read English * Able to provide informed consent
Exclusion criteria
* Metastatic disease * Continued cancer treatment * Psychiatric or neurological disorders that could interfere with study participation * Vulnerable populations will not be included
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Satisfaction assessed by study-specific survey during the intervention - Acceptability | During intervention | The intervention will be deemed acceptable if, on average, participants report satisfaction with the weekly sessions as ≥2 on a 0-4 scale. |
| Satisfaction assessed by study-specific survey after the intervention - Acceptability | Immediately after the intervention | The intervention will be deemed acceptable if, on average, participants report satisfaction with the overall program and intent to continue using the intervention skills as ≥2 on a 0-4 scale. |
| Session attendance after the intervention - Acceptability | Immediately after the intervention | Videoconference delivery will be acceptable if average group attendance is ≥6/10 sessions. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Quality of life before intervention | Baseline | Participants will complete the 27-item Functional Assessment of Cancer Therapy - General |
| Change in quality of life at after intervention | Immediately after intervention | Participants will complete the 27-item Functional Assessment of Cancer Therapy - General |
Other
| Measure | Time frame | Description |
|---|---|---|
| Cancer-related distress before intervention | Baseline | Participants will complete the 22-item Impact of Event Scale-Revised |
| Change in stress management skills self-efficacy after intervention | Immediately after intervention | Participants will complete subscales from the Measure of Current Status |
| Stress management skills self-efficacy before intervention | Baseline | Participants will complete subscales from the Measure of Current Status |
| Change in cancer-related distress after intervention | Immediately after intervention | Participants will complete the 22-item Impact of Event Scale-Revised |
| Coping before intervention | Baseline | Participants will complete the Brief-COPE |
| Change in coping after intervention | Immediately after intervention | Participants will complete the Brief-COPE |
| Symptom burden before intervention | Baseline | Participants will complete the 22-item Impact of Event Scale-Revised |
| Change in Symptom burden after intervention | Immediately after intervention | Participants will complete the 22-item Impact of Event Scale-Revised |
Countries
United States